Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Vir Biotechnology, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
vir.bioAI Executive Summary
AI-powered analysis of 8-K filing content
Vir Biotechnology appointed Aziz Sawaf as Executive Vice President and Chief Financial Officer effective October 5, 2026, while Brent Sabatini transitions from interim CFO to Senior Vice President and Chief Accounting Officer. This leadership change in financial management could influence the company's strategic financial direction.
Key Takeaways
Aziz Sawaf, with credentials including MBEE, MBA, and CFA, assumes the permanent CFO role, ending the interim period under Brent Sabatini
Brent Sabatini retains a senior financial role as Chief Accounting Officer, ensuring continuity in accounting operations
2 more takeaways
Related Filings (1)
1 more filing from Vir Biotechnology, Inc. in the last 90 days
Filing Overview
What This Means
Vir Biotechnology, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.